Cytoplasmic laminin expression correlates with poor patient prognosis in pancreatic cancer [48] and has been shown as one of the most efficient ECM proteins to promote cell adhesion-mediated drug resistance [49]. This evidence concerns the gene LAMB2 and pancreatic neoplasm.